Zymeworks to Report Second Quarter 2026 Financial Results on August 6

GlobeNewswire··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Zymeworks announced it will report its second quarter 2026 financial results after market close on August 6, 2026. The company has elected not to host a second quarter earnings conference call in light of the previously announced proposed acquisition of Theravance Biopharma. Zymeworks stated it looks forward to providing an update following the expected closing of the acquisition, sharing greater visibility into the combined business and its strategic priorities.

Impact on assets 2

Biotech & Genomic Medicine▲ · 2 stocks
Zymeworks Inc. Common Stock
ZYME
± MixedCapitalrelevance

Zymeworks reports earnings but will not host a call due to the Theravance acquisition; no financial results or deal updates are provided.

Theravance Biopharma Inc
TBPH
± MixedCapitalrelevance

Theravance Biopharma is the acquisition target; the news is about Zymeworks' earnings schedule and the acquisition, but no new details on the deal's impact.

© 2026 MarketIVNews